Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

Detalles Bibliográficos
Autores principales: Carpenedo, Monica, Zappaterra, Arianna, Ferrari, Beatrice, Cotilli, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000878/
https://www.ncbi.nlm.nih.gov/pubmed/36908865
http://dx.doi.org/10.4084/MJHID.2023.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000878/
https://www.ncbi.nlm.nih.gov/pubmed/36908865
http://dx.doi.org/10.4084/MJHID.2023.021

Ejemplares similares